Sterling Capital Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.63K	Buy	81 +14	+21%	+$281	﹤0.01%	2972
2025 Q1	$1.32K	Sell	67 -28	-29%	-$551	﹤0.01%	2722
2024 Q4	$2.14K	Buy	95 +55	+138%	+$1.24K	﹤0.01%	2768
2024 Q3	$1.02K	Buy	+40	New	+$1.02K	﹤0.01%	2518